OurWork-sub.jpg

Clinical
Studies


Now enrolling

Freenome is currently seeking patients to participate in observational research studies, helping to transform the way doctors detect and treat cancer at its earliest, most manageable stages.

 

The first Freenome study in the AI-PATTERNS oncology series, AI-EMERGE, is focused on colorectal cancer screening.

 

AI-EMERGE Study


Join a paid research study of a blood-based screening test for the early detection of colorectal cancer and precancerous lesions known as advanced adenomas.

Currently enrolling patients who are:

  • At least 18 years of age – recently diagnosed with colorectal cancer or advanced adenoma (pre-cancer)

  • Ages 50 to 84 – undergoing a routine screening colonoscopy

Participation does not involve taking any medication or treatment. It simply requires a blood sample and the sharing of relevant medical records.

Click here for a list of study sites and additional details.

 

Help make
cancer history

Get connected with the study site
nearest to you by emailing

clinicalstudy@freenome.com

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software like Aldus PageMaker including versions of Lorem Ipsum

Study background

Despite the importance of detecting and treating colorectal cancer as early as possible, many people consider current screening tests, such as colonoscopy or stool-based testing, inconvenient or uncomfortable. As a result, millions avoid recommended screenings.

An artificial intelligence (AI) powered blood test like the one Freenome is developing may boost screening rates and help save lives by providing an accurate, convenient, and patient-friendly alternative for current and future generations. Your participation can make a difference.

 

Interested in collaborating on Freenome clinical trials?

 

Are you a study investigator or research site interested in collaborating with Freenome? Please email research@freenome.com for more information.